#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Langerhans' cell histiocytosis Asthma Bronchiectasis Hereditary neuropathic amyloidosis Chronic inflammatory demyelinating polyradiculoneuropathy Liposarcoma metastatic Small for dates baby Barth syndrome Thrombotic microangiopathy Subdural haematoma Anti-myelin-associated glycoprotein antibodies positive Acute respiratory distress syndrome Progressive familial intrahepatic cholestasis Small intestine leiomyosarcoma Solitary fibrous tumour More trials…

    Learn about Rare Diseases

    Shprintzen-Goldberg syndrome – Life with Disease MELAS syndrome – Diagnostics Marginal zone lymphoma refractory – Life with Disease Pituitary-dependent Cushing’s syndrome – Treatment Angelman’s syndrome – Diagnostics Small intestine leiomyosarcoma – Life with Disease Inclusion body myositis – Treatment Pemphigoid – Trials in Disease Small intestine leiomyosarcoma – Trials in Disease Breast angiosarcoma – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Mesna Lacnotuzumab Lonapegsomatropin Paracetamol Cdr132L Sodium Ecoo75 Zenocutuzumab Tezepelumab Epinephrine Hydrochloride Msv-Allo Sultiame Df1001 Guanfacine Insulin Lispro Abiraterone Mva-209-Fsp-B4 Mirabegron Berubicin Hydrochloride Vonafexor Nepafenac More therapies…

    Learn about Your Condition

    Extra-osseous Ewing's sarcoma Infant sedation Follicular lymphoma stage IV Nephrogenic anaemia Vulvovaginal discomfort Kidney transplant rejection Tubulointerstitial nephritis Cutaneous sarcoidosis Desmoplastic melanoma Myositis Retinal neovascularisation Hypoaesthesia Medullary thyroid cancer Angiosarcoma Uveal melanoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Prostate cancer

  • Study on High-Risk Prostate Cancer Treatment Using Darolutamide, Relugolix, and Drug Combination for Eligible Patients

    Recruiting

    4 1 1
    Investigated Diseases:
    • Prostate cancer
    Investigated Drugs:
    • Goserelin Acetate
    • Relugolix
    • Triptorelin
    Belgium Spain

  • Long-term Safety Study of Niraparib for Patients with Advanced Ovarian, Breast, or Prostate Cancer Who Completed a Previous Niraparib Study

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Ovarian cancer
    • Breast cancer
    • Prostate cancer
    Investigated Drugs:
    • Niraparib Tosilate Monohydrate
    Austria France Germany Italy Romania Spain

  • Study of Lutetium (177Lu) Vipivotide Tetraxetan for Patients with High-Risk Localized or Locally Advanced Prostate Cancer Eligible for Surgery

    Recruiting

    1 1 1 1
    Investigated Drugs:
    • Lutetium (177Lu) Vipivotide Tetraxetan
    Germany

  • Study on Shortened Treatment with Apalutamide and Enzalutamide for Patients with Low-Volume Metastatic Castration-Sensitive Prostate Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Prostate cancer
    Investigated Drugs:
    • Goserelin Acetate
    • Leuprorelin
    • Triptorelin
    The Netherlands

  • Study on the Use of [18F]PSMA-1007 PET/CT Imaging for Detecting Prostate Cancer in Patients with Newly Diagnosed High-Risk or Very-High-Risk Conditions

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • (2S)-2-[[(1S)-1-Carboxy-5-[[(2S)-2-[[4-[[[(2S)-4-Carboxy-2-[[(2S)-4-Carboxy-2-[(6-(18F)Fluoranylpyridine-3-Carbonyl)Amino]Butanoyl]Amino]Butanoyl]Amino]Methyl]Benzoyl]Amino]-3-Naphthalen-2-Ylpropanoyl]Amino]Pentyl]Carbamoylamino]Pentanedioic Acid
    France Germany Italy The Netherlands Spain

  • Study on How Degarelix and Drug Combination Affect Gut Health in Patients with Prostate Cancer or Benign Prostate Hyperplasia

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Benign prostatic hyperplasia
    • Prostate cancer
    Investigated Drugs:
    • Dutasteride
    • Finasteride
    • Tamsulosin Hydrochloride
    Finland
Previous Page
1 … 3 4 5 6 7 … 17
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!